Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03752021 · ClinicalTrials.gov registry record
The Endocannabinoid System in Human Gestational Tissues in Labor
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 20
- Enrollment target
NCT03752021: Completed study, sponsored by Wake Forest University Health Sciences.
NCT03752021 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03752021 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine if the endocannabinoid (a biological system) plays a role in the labor process.
Primary Outcome
Identification of CB1 receptor protein interacting protein (CRIP) in gestational membranes, placenta, and myometrium
Interventions
- PROCEDURE Myometrial Sampling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-01-25 |
| Est. Completion | 2019-07-01 |
What the finished NCT03752021 record still lists
NCT03752021 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Myometrial Sampling is the first listed.
NCT03752021 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03752021 about?
NCT03752021 is a clinical study titled "The Endocannabinoid System in Human Gestational Tissues in Labor". The purpose of this research study is to determine if the endocannabinoid (a biological system) plays a role in the labor process.
What is the current status of trial NCT03752021?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2019-01-25. Estimated completion is 2019-07-01.
What interventions are being tested in trial NCT03752021?
The interventions under investigation include: Myometrial Sampling (PROCEDURE).
Who is sponsoring clinical trial NCT03752021?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI